|
|
|
51-200 employees
View all
|
|
Medical Device
|
|
Suite 100,Newton,MA,US
|
|
Alcresta Therapeutics | 982 followers on LinkedIn. Fulfilling potential: With the Science of Enzymes | Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.
The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases.
The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA).
|
Alcresta Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Alcresta Therapeutics email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Alcresta Therapeutics customer service number call here 617-431-3600. To contact Alcresta Therapeutics customer service number in your country click here to find.
Daniel Orlando is the CEO of Alcresta Therapeutics. To contact Daniel Orlando email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.